Ann M Kapoun

Ann M Kapoun

UNVERIFIED PROFILE

Are you Ann M Kapoun?   Register this Author

Register author
Ann M Kapoun

Ann M Kapoun

Publications by authors named "Ann M Kapoun"

Are you Ann M Kapoun?   Register this Author

34Publications

779Reads

35Profile Views

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.

Gynecol Oncol 2019 08 4;154(2):294-301. Epub 2019 Jun 4.

Memorial Sloan Kettering Cancer Center New York, NY and Weill Cornell Medical College, New York, NY, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.04.001DOI Listing
August 2019

Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.

J Clin Oncol 2017 Jan 21;35(3):352-360. Epub 2016 Nov 21.

Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick Zweidler-McKay, Diana Bell, William N. William Jr, Bonnie S. Glisson, J. Jack Lee, Andrew Futreal, Adel K. El-Naggar, and John V. Heymach, University of Texas MD Anderson Cancer Center, Houston; Michael J. Wick and Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Ann M. Kapoun, Leonardo Faoro, and Jakob Dupont, OncoMed Pharmaceuticals, Redwood City; Pamela Munster, University of California San Francisco, San Francisco, CA; and Gail Eckhardt, University of Colorado Denver School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.5264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456373PMC
January 2017

Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.

Cancer Res 2011 Mar 30;71(5):1520-5. Epub 2010 Dec 30.

OncoMed Pharmaceuticals, Inc., Redwood City, California 94063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2817DOI Listing
March 2011

Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.

Am J Respir Crit Care Med 2005 Apr 24;171(8):889-98. Epub 2004 Nov 24.

Department of Pathology and Molecular Medicine, McMaster University, 1200 Main Street West, Room 2N16, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://www.atsjournals.org/doi/abs/10.1164/rccm.200405-612OC
Publisher Site
http://dx.doi.org/10.1164/rccm.200405-612OCDOI Listing
April 2005

Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis.

J Am Soc Nephrol 2003 Feb;14(2):338-51

Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.asn.0000048715.12315.fdDOI Listing
February 2003